Urology · Dover, DE
NPI
1205821881
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
200 Banning St, Suite 250
Dover, DE, 19904
Phone (302) 736-1320
Groups this clinician bills Medicare through
Medicare paid, 2024
$638K
23,514 services
Medicare patients, 2024
1,131
Average age 77
Drug cost, 2024
$785K
3,182 prescriptions
Company payments, 2025
$905
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael R Zaragoza was code 87798 (infectious agent detection by dna/rna), 3,978 times for 194 patients. In total Michael R Zaragoza billed 23,514 services in 109 codes, and Medicare paid $638K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 87798 Infectious Agent Detection by DNA/RNA | Office | 3,978 | 194 | $34.28 | $136K |
| 84311 Immunoassay | Office | 1,670 | 703 | $7.88 | $13K |
| 99214 Office E&M - Established | Office | 1,536 | 797 | $97.28 | $149K |
| J9030 Bcg live intravesical instillation, 1 mg | Office | 1,500 | 17 | $2.28 | $3,423 |
| 81003 Clinical Chemistry | Office | 886 | 701 | $2.19 | $1,937 |
| 82010 Clinical Chemistry | Office | 837 | 703 | $7.95 | $6,650 |
| 82247 Clinical Chemistry | Office | 837 | 703 | $4.88 | $4,085 |
| 82570 Clinical Chemistry | Office | 837 | 704 | $5.04 | $4,217 |
| 83986 Clinical Chemistry | Office | 836 | 703 | $3.48 | $2,910 |
| 84156 Clinical Chemistry | Office | 836 | 703 | $3.57 | $2,985 |
| 83069 Blood Count | Office | 836 | 703 | $3.84 | $3,209 |
| 82945 Clinical Chemistry | Office | 834 | 702 | $3.82 | $3,185 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 762 | 590 | $13.71 | $10K |
| 81007 Clinical Chemistry | Office | 726 | 618 | $29.10 | $21K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 633 | 137 | $53.00 | $34K |
By year: 2022 $606K for 16,624 services; 2023 $558K for 15,898 services; 2024 $638K for 23,514 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87798 Infectious Agent Detection by DNA/RNA | 3,978 | 194 | $34.28 | $136K |
| 84311 Immunoassay | 1,670 | 703 | $7.88 | $13K |
| 81003 Clinical Chemistry | 886 | 701 | $2.19 | $1,937 |
| 82010 Clinical Chemistry | 837 | 703 | $7.95 | $6,650 |
| 82247 Clinical Chemistry | 837 | 703 | $4.88 | $4,085 |
| 82570 Clinical Chemistry | 837 | 704 | $5.04 | $4,217 |
| 84156 Clinical Chemistry | 836 | 703 | $3.57 | $2,985 |
| 83069 Blood Count | 836 | 703 | $3.84 | $3,209 |
| 83986 Clinical Chemistry | 836 | 703 | $3.48 | $2,910 |
| 82945 Clinical Chemistry | 834 | 702 | $3.82 | $3,185 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael R Zaragoza prescribed most often to Medicare patients was Tamsulosin Hcl, with 625 prescriptions and refills. In total Michael R Zaragoza wrote 3,182 Medicare prescriptions that cost $785K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 625 | 1,762 | 180 | $16K |
| Myrbetriq Mirabegron | 303 | 669 | 73 | $290K |
| Imipramine Hcl Generic | 214 | 560 | 58 | $4,443 |
| Finasteride Generic | 173 | 493 | 49 | $3,468 |
| Dutasteride Generic | 155 | 436 | 42 | $8,598 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 111 | 191 | 62 | $2,315 |
| Silodosin Generic | 111 | 275 | 28 | $12K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 110 | 118 | 74 | $1,448 |
| Ciprofloxacin Hcl Generic | 104 | 139 | 71 | $815 |
| Gemtesa Vibegron | 101 | 233 | 35 | $106K |
| Cephalexin Generic | 96 | 167 | 55 | $3,893 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 92 | 270 | 24 | $3,124 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 81 | 230 | 30 | $3,957 |
| Solifenacin Succinate Generic | 80 | 220 | 22 | $6,331 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 75 | 191 | 19 | $3,273 |
Brand drugs: 516 claims; generic drugs: 2,666 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael R Zaragoza $905 ($905 in general payments such as food, travel and fees) from 19 companies. The largest payer was Sumitomo Pharma America, Inc. with $193.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 14 | $193 |
| Immunitybio, Inc. IBRX | 4 | $89.93 |
| Progenics Pharmaceuticals, Inc. | 3 | $73.27 |
| Astellas Pharma US Inc 4503.T | 2 | $53.76 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $53.18 |
| Bioprotect Medical, Inc. | 3 | $52.54 |
| Janssen Biotech, Inc. JNJ | 2 | $50 |
| Merck Sharp & Dohme LLC MRK | 2 | $49.62 |
| Ferring Pharmaceuticals Inc. | 2 | $43.66 |
| Pfizer Inc. PFE | 2 | $34.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.